- About
- Resource Library
- Collections
- Events
Virtual Event – Strategies To Optimize Patient Outcomes In Bipolar I Disorder: The Role Of Long-Acting Injectable Antipsychotics
Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:
About This Event
Virtual Event – Strategies To Optimize Patient Outcomes In Bipolar I Disorder: The Role Of Long-Acting Injectable Antipsychotics
This is a Virtual Event for PsychU members in D.C., Maryland, North Carolina, South Carolina and Virginia.
In “Strategies To Optimize Patient Outcomes In Bipolar I Disorder: The Role Of Long-Acting Injectable Antipsychotics,” the objectives of this presentation are to understand the impact of mood episode recurrence in bipolar I disorder on patient functioning and clinical outcomes, discuss risk factors for mood episode recurrence, including nonadherence, in patients with bipolar I disorder, and review management strategies, including long-acting injectable antipsychotics (LAIs), to optimize patient outcomes in bipolar I disorder.
Dennis Sholler, PhD (OPDC)
Clinical & Scientific Liaison
Amica Simmons-Yon, PharmD, PhD (OPDC)
Clinical & Scientific Liaison
Miranda Fisher, PhD (OPDC)
Clinical & Scientific Liaison
Speakers Dennis Sholler, PhD; Amica Simmons-Yon, PharmD, PhD; and Miranda Fisher, PhD are employees of Otsuka Pharmaceutical Development & Commercialization, Inc.
Related Events
Registration
- Resource Library
